Methylation Alterations in Multiple Myeloma as a Model for Epigenetic Changes in Cancer
TABLE 2 | Methylation implicated in malignant transformation of monoclonal gammopathy of uncertain significance (MGUS) to Multiple Myeloma (MM) P16 (CDKN2A) P16 is an inhibitor of cyclin-dependent kinases (CDKs) and…